AMC Entertainment Holdings Inc (NYSE:AMC) to report Q4 earnings, with expected loss of 18 cents/share and $1.30B in revenues.

Both of these metrics are at their most attractive levels in the company's history, making this a once-in-a-decade opportunity. Its discounted price combined with a long track record of steady growth, ...

The FDA’s decision will threaten the ability of compounding pharmacies to make far cheaper, unbranded versions of the ...

What is the outlook of the AMC stock price ahead of its earnings? We explain why a short squeeze is highly likely ...

Novo Nordisk (NYSE: NVO) has long been a high-quality pharmaceutical company with a focus on diabetes, producing consistent financial results and investor returns. But its stock p ...

An interesting thread running through the current narrative is a bit intellectual and structural for my liking, but still ...

JNJ's $14B acquisition of ITCI bolsters its portfolio with Caplyta, showing strong sales and patent protection until 2033.

Reliance Industries has slipped below the crucial ₹1,200 mark, leaving investors anxious about its future trajectory. After a ...

Former pacer S Sreesanth feels that the brotherhood within the Indian team is their biggest strength as they reached the ...

Gilead Sciences' Q4 2024 results, driven by HIV drug demand and Trodelvy growth, make it a compelling choice for long-term ...

The loss of bullish momentum has so far not caused any major breakdowns of key support levels to scare away the bulls just ...